NP / PA
Mariano D Cibran, MD Corp Dba ST Petersburg Pediatrics
Mariano D Cibran, MD Corp Dba ST Petersburg Pediatrics was paid $30.14M by Medicaid between Jan 2019 and Dec 2024, across 80 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoMARIANO D CIBRAN, MD CORP DBA ST PETERSBURG PEDIATRICS
ST PETERSBURG, FL 33713
ST PETERSBURG, FL 33713
33aNPI1578640181assigned 11/01/2006
33bProvider typePediatric Nurse Practitioner
28Total paid$30.14M
24GClaims1,121,102
24DCodes billed80
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Florida
Rank by total paid#1 of 18
Median peer was paid$20K
This provider vs. median1,528×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 161,195 | $5.38M | |
| 2020 | 129,152 | $4.19M | |
| 2021 | 148,122 | $5.90M | |
| 2022 | 377,650 | $5.31M | |
| 2023 | 151,683 | $5.83M | |
| 2024incomplete | 153,300 | $3.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 122,273 | 85,129 | $9.10M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 160,239 | 116,779 | $7.48M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 35,520 | 26,343 | $3.05M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.9% | 34,222 | 25,131 | $2.67M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 30,233 | 21,789 | $2.21M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.8% | 84,797 | 63,031 | $2.06M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.5% | 18,052 | 12,489 | $1.36M |
| 90461 | 3.3% | 48,421 | 34,035 | $983K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,284 | 8,312 | $256K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 22,509 | 13,332 | $184K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 79,772 | 57,348 | $108K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 21,137 | 12,651 | $95K |
68 more codes
| 99188 | <1% | 21,233 | $82K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26,641 | $80K |
| 99460 | <1% | 822 | $43K | |
| 99051 | <1% | 21,228 | $43K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 706 | $30K |
| 83655 | <1% | 11,739 | $29K | |
| 87428 | <1% | 5,254 | $28K | |
| 90686 | <1% | 9,076 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,950 | $22K |
| 90670 | <1% | 18,239 | $20K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,415 | $18K |
| 81002 | <1% | 40,962 | $17K | |
| 87807 | <1% | 5,453 | $15K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 24,171 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,154 | $13K |
| 90677 | <1% | 2,745 | $12K | |
| 90633 | <1% | 12,546 | $11K | |
| 90647 | <1% | 15,119 | $9K | |
| 99080 | <1% | 573 | $8K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,922 | $7K |
| 99072 | <1% | 20,250 | $6K | |
| 99383 | <1% | 50 | $5K | |
| 90696 | <1% | 2,952 | $4K | |
| 99381 | <1% | 63 | $4K | |
| 90710 | <1% | 3,349 | $4K | |
| 92551 | <1% | 66,349 | $4K | |
| 90681 | <1% | 5,958 | $4K | |
| 90651 | <1% | 8,685 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 233 | $3K |
| 90688 | <1% | 1,447 | $3K | |
| 0072A | <1% | 318 | $3K | |
| 99384 | <1% | 42 | $2K | |
| 94664 | <1% | 784 | $2K | |
| 90723 | <1% | 15,144 | $2K | |
| 90707 | <1% | 2,070 | $2K | |
| 0071A | <1% | 203 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 112 | $1K |
| 90700 | <1% | 1,326 | $1K | |
| 90715 | <1% | 3,506 | $964.74 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 996 | $943.92 |
| 86318 | <1% | 335 | $877.35 | |
| 99382 | <1% | 67 | $848.64 | |
| 0001A | <1% | 145 | $668.25 | |
| 90620 | <1% | 1,255 | $558.63 | |
| 91300 | <1% | 135 | $545.73 | |
| 90716 | <1% | 2,326 | $512.59 | |
| 99173 | <1% | 69,920 | $242.33 | |
| 90734 | <1% | 6,518 | $220.74 | |
| 0002A | <1% | 134 | $192.00 | |
| 69210 | <1% | 135 | $139.76 | |
| 82948 | <1% | 338 | $130.97 | |
| 81025 | <1% | 77 | $116.48 | |
| 96161 | <1% | 321 | $77.52 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $35.25 |
| 90685 | <1% | 12 | $24.01 | |
| 96127 | <1% | 561 | $17.88 | |
| 85018 | <1% | 497 | $4.29 | |
| 90648 | 0% | 50 | $0.00 | |
| 90661 | 0% | 19 | $0.00 | |
| 80061 | Lipid panel | 0% | 16 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 13 | $0.00 |
| 90656 | 0% | 81 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 15 | $0.00 |
| 92567 | 0% | 166 | $0.00 | |
| 36416 | 0% | 153 | $0.00 | |
| 91307 | 0% | 243 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 213 | $0.00 |
| 91305 | 0% | 101 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCIBRAN, MARIANO (PRESIDENT)